O	0	14	Overexpression	Overexpression	NN	B-NP
O	15	17	of	of	IN	B-PP
O	18	21	Bax	Bax	NN	B-NP
O	22	31	inhibitor	inhibitor	NN	I-NP
O	31	32	-	-	HYPH	B-NP
O	32	33	1	1	CD	I-NP
O	34	35	(	(	(	O
O	35	37	BI	BI	NN	B-NP
O	37	38	-	-	HYPH	B-NP
O	38	39	1	1	CD	I-NP
O	39	40	)	)	)	O
O	41	48	induces	induce	VBZ	B-VP
B-Cell	49	53	cell	cell	NN	B-NP
O	54	68	transformation	transformation	NN	I-NP
O	69	71	in	in	IN	B-PP
B-Cell	72	78	NIH3T3	NIH3T3	NN	B-NP
I-Cell	79	84	cells	cell	NNS	I-NP
O	84	85	.	.	.	O

O	87	89	BI	BI	NN	B-NP
O	89	90	-	-	HYPH	B-NP
O	90	91	1	1	CD	I-NP
O	92	93	(	(	(	O
O	93	96	Bax	Bax	NN	B-NP
O	97	106	inhibitor	inhibitor	NN	I-NP
O	106	107	-	-	HYPH	B-NP
O	107	108	1	1	CD	I-NP
O	108	109	)	)	)	O
O	109	110	,	,	,	O
O	111	113	an	an	DT	B-NP
O	114	123	apoptosis	apoptosis	NN	I-NP
O	123	124	-	-	HYPH	O
O	124	134	inhibiting	inhibit	VBG	B-VP
O	135	139	gene	gene	NN	B-NP
O	140	149	belonging	belong	VBG	B-VP
O	150	152	to	to	TO	B-PP
O	153	156	the	the	DT	B-NP
O	157	160	Bcl	Bcl	NN	I-NP
O	160	161	-	-	HYPH	B-NP
O	161	162	2	2	CD	I-NP
O	163	170	protein	protein	NN	I-NP
O	171	177	family	family	NN	I-NP
O	177	178	,	,	,	O
O	179	184	plays	play	VBZ	B-VP
O	185	187	an	an	DT	B-NP
O	188	197	important	important	JJ	I-NP
O	198	202	role	role	NN	I-NP
O	203	205	in	in	IN	B-PP
B-Cellular_component	206	219	mitochondrial	mitochondrial	JJ	B-NP
O	220	229	apoptosis	apoptosis	NN	I-NP
O	230	237	pathway	pathway	NN	I-NP
O	238	240	to	to	TO	B-VP
O	241	249	suppress	suppress	VB	I-VP
O	250	253	Bax	Bax	NN	B-NP
O	253	254	-	-	HYPH	B-NP
O	254	261	induced	induce	VBN	I-NP
O	262	271	apoptosis	apoptosis	NN	I-NP
O	271	272	.	.	.	O

O	273	275	To	To	TO	B-VP
O	276	287	investigate	investigate	VB	I-VP
O	288	291	the	the	DT	B-NP
O	292	301	potential	potential	JJ	I-NP
O	302	306	role	role	NN	I-NP
O	307	309	of	of	IN	B-PP
O	310	312	BI	BI	NN	B-NP
O	312	313	-	-	HYPH	B-NP
O	313	314	1	1	CD	I-NP
O	315	317	in	in	IN	B-PP
O	318	327	promoting	promote	VBG	B-VP
B-Cell	328	332	cell	cell	NN	B-NP
O	333	339	growth	growth	NN	I-NP
O	340	343	and	and	CC	O
O	344	357	tumorigenesis	tumorigenesis	NN	B-NP
O	357	358	,	,	,	O
O	359	361	in	in	IN	B-PP
O	362	365	the	the	DT	B-NP
O	366	373	present	present	JJ	I-NP
O	374	379	study	study	NN	I-NP
O	380	382	we	we	PRP	B-NP
O	383	396	overexpressed	overexpresse	VBD	B-VP
O	397	400	the	the	DT	B-NP
O	401	403	BI	BI	NNP	I-NP
O	403	404	-	-	HYPH	I-NP
O	404	405	1	1	CD	I-NP
O	406	410	gene	gene	NN	I-NP
O	411	413	in	in	IN	B-PP
B-Cell	414	420	NIH3T3	NIH3T3	NN	B-NP
I-Cell	421	426	cells	cell	NNS	I-NP
O	427	432	using	use	VBG	B-VP
O	433	436	the	the	DT	B-NP
O	437	447	lentivirus	lentivirus	NN	I-NP
O	447	448	-	-	HYPH	B-NP
O	448	456	mediated	mediate	VBN	I-NP
O	457	461	gene	gene	NN	I-NP
O	462	472	expression	expression	NN	I-NP
O	473	479	system	system	NN	I-NP
O	479	480	.	.	.	O

O	481	484	Our	Our	PRP$	B-NP
O	485	487	in	in	FW	I-NP
O	488	493	vitro	vitro	FW	I-NP
O	494	501	studies	study	NNS	I-NP
O	502	508	showed	show	VBD	B-VP
O	509	513	that	that	IN	B-SBAR
B-Cell	514	520	NIH3T3	NIH3T3	NN	B-NP
I-Cell	521	526	cells	cell	NNS	I-NP
O	527	541	overexpressing	overexpresse	VBG	B-VP
O	542	544	BI	BI	NN	B-NP
O	544	545	-	-	HYPH	B-NP
O	545	546	1	1	CD	I-NP
O	547	556	displayed	display	VBD	B-VP
O	557	558	a	a	DT	B-NP
O	559	572	significantly	significantly	RB	I-NP
O	573	579	higher	high	JJR	I-NP
O	580	586	growth	growth	NN	I-NP
O	587	591	rate	rate	NN	I-NP
O	592	595	and	and	CC	O
O	596	602	formed	form	VBD	B-VP
O	603	607	more	more	JJR	B-NP
O	608	611	and	and	CC	I-NP
O	612	618	larger	large	JJR	I-NP
B-Cell	619	627	colonies	colony	NNS	I-NP
O	628	632	than	than	IN	B-PP
O	633	636	the	the	DT	B-NP
O	637	644	control	control	NN	I-NP
B-Cell	645	650	cells	cell	NNS	I-NP
O	650	651	.	.	.	O

O	652	654	In	In	IN	B-PP
O	655	663	addition	addition	NN	B-NP
O	663	664	,	,	,	O
O	665	668	our	our	PRP$	B-NP
O	669	671	in	in	FW	I-NP
O	672	676	vivo	vivo	FW	I-NP
O	677	684	studies	study	NNS	I-NP
O	685	694	indicated	indicate	VBD	B-VP
O	695	699	that	that	IN	B-SBAR
O	700	703	the	the	DT	B-NP
O	704	709	lenti	lenti	AFX	I-NP
O	709	710	-	-	HYPH	I-NP
O	710	712	BI	BI	NN	I-NP
O	712	713	-	-	HYPH	I-NP
O	713	714	1	1	CD	I-NP
O	714	715	-	-	HYPH	I-NP
O	715	723	infected	infect	VBN	I-NP
B-Cell	724	729	cells	cell	NNS	I-NP
O	730	736	formed	form	VBD	B-VP
O	737	744	obvious	obvious	JJ	B-NP
B-Cancer	745	752	tumours	tumour	NNS	I-NP
O	752	753	,	,	,	O
O	754	759	while	while	IN	B-SBAR
O	760	762	no	no	DT	B-NP
B-Cancer	763	770	tumours	tumour	NNS	I-NP
O	771	775	were	be	VBD	B-VP
O	776	782	formed	form	VBN	I-VP
O	783	785	by	by	IN	B-PP
O	786	789	the	the	DT	B-NP
O	790	797	control	control	NN	I-NP
B-Cell	798	803	cells	cell	NNS	I-NP
O	804	809	after	after	IN	B-PP
B-Immaterial_anatomical_entity	810	824	subcutaneously	subcutaneously	RB	B-NP
O	825	833	injected	inject	VBN	B-VP
O	834	838	into	into	IN	B-PP
O	839	843	nude	nude	JJ	B-NP
O	844	848	mice	mouse	NNS	I-NP
O	848	849	.	.	.	O

O	850	855	These	These	DT	B-NP
O	856	863	results	result	NNS	I-NP
O	864	872	strongly	strongly	RB	B-VP
O	873	882	suggested	suggest	VBD	I-VP
O	883	887	that	that	IN	B-SBAR
O	888	891	the	the	DT	B-NP
O	892	894	BI	BI	NNP	I-NP
O	894	895	-	-	HYPH	I-NP
O	895	896	1	1	CD	I-NP
O	897	901	gene	gene	NN	I-NP
O	902	907	might	might	MD	B-VP
O	908	912	play	play	VB	I-VP
O	913	914	a	a	DT	B-NP
O	915	922	crucial	crucial	JJ	I-NP
O	923	927	role	role	NN	I-NP
O	928	930	in	in	IN	B-PP
B-Cancer	931	941	neoplastic	neoplastic	JJ	B-NP
O	942	949	genesis	genesis	NN	I-NP
O	950	953	and	and	CC	I-NP
O	954	965	development	development	NN	I-NP
O	965	966	.	.	.	O

